Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
2.820
-0.190 (-6.31%)
At close: Mar 18, 2026, 4:00 PM EDT
2.810
-0.010 (-0.35%)
After-hours: Mar 18, 2026, 4:10 PM EDT
LIXT Market Cap
LIXT has a market cap or net worth of $16.09 million as of March 18, 2026. Its market cap has increased by 495.77% in one year.
Market Cap
16.09M
Enterprise Value
14.11M
1-Year Change
495.77%
Ranking
Category
Stock Price
$2.82
Market Cap Chart
Since November 25, 2020, LIXT's market cap has decreased from $47.40M to $16.09M, a decrease of -66.06%. That is a compound annual growth rate of -18.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 17.20M | -23.21% |
| Dec 31, 2025 | 22.40M | 386.96% |
| Dec 31, 2024 | 4.60M | -13.21% |
| Dec 29, 2023 | 5.30M | -37.65% |
| Dec 30, 2022 | 8.50M | -48.17% |
| Dec 31, 2021 | 16.40M | -59.20% |
| Dec 31, 2020 | 40.20M | -15.19% |
| Nov 25, 2020 | 47.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allarity Therapeutics | 19.92M |
| VYNE Therapeutics | 19.54M |
| Pasithea Therapeutics | 18.93M |
| IN8bio | 18.61M |
| Lexaria Bioscience | 17.42M |
| Intensity Therapeutics | 17.18M |
| Genenta Science | 16.85M |
| Serina Therapeutics | 16.53M |